Table 1.
Significant KEGG pathways on the consensus network
| Pathway | No. exp. | No. obs. | Sig. |
|---|---|---|---|
| genes | genes | value | |
| MAPK signaling pathway | 18 | 69 | 1.6−25 |
| Natural killer cell-mediated cytotoxicity | 9 | 34 | 1.39−11 |
| Apoptosis | 5 | 25 | 9.29−11 |
| Epithelial cell sig. in Helicobacter pylori infection | 3 | 17 | 5.01−10 |
| Focal adhesion | 9 | 26 | 2.52−06 |
| Adherens junction | 5 | 18 | 1.38−05 |
| T-cell receptor signaling pathway | 5 | 18 | 1.46−05 |
| Chronic myeloid leukemia | 4 | 16 | 1.65−05 |
| Fc epsilon RI signaling pathway | 4 | 16 | 1.85−05 |
| Toll-like receptor signaling pathway | 5 | 17 | 5.53−05 |
| Colorectal cancer | 2 | 10 | 9.40−05 |
| Pancreatic cancer | 4 | 14 | 0.0001 |
| Cytokine–cytokine receptor interaction | 14 | 30 | 0.0001 |
| Adipocytokine signaling pathway | 4 | 14 | 0.0001 |
| mTOR signaling pathway | 2 | 10 | 0.0002 |
| GnRH signaling pathway | 6 | 17 | 0.0003 |
| B-cell receptor signaling pathway | 4 | 11 | 0.0013 |
| Insulin signaling pathway | 9 | 20 | 0.0013 |
| Cell cycle | 5 | 13 | 0.0014 |
| Glioma | 4 | 11 | 0.003 |
| Type II diabetes mellitus | 3 | 9 | 0.0033 |
| VEGF signaling pathway | 5 | 12 | 0.0059 |
| Type I diabetes mellitus | 0 | 3 | 0.0059 |
| Leukocyte transendothelial migration | 5 | 11 | 0.0135 |
| Axon guidance | 8 | 15 | 0.0173 |
| Maturity onset diabetes of the young | 2 | 5 | 0.0386 |